Baricitinib : Baricitinib: Therapeutic Potential for Moderate to Severe Atopic Dermatitis
MK-8353: 33-kDa ANXA3 isoform contributes to hepatocarcinogenesis via modulating ERK, PI3K/Akt-HIF and intrinsic apoptosis pathways
Baricitinib : Baricitinib: Therapeutic Potential for Moderate to Severe Atopic Dermatitis
MK-8353: 33-kDa ANXA3 isoform contributes to hepatocarcinogenesis via modulating ERK, PI3K/Akt-HIF and intrinsic apoptosis pathways